Full Text View
Tabular View
No Study Results Posted
Related Studies
Evaluating the Safety and Immunogenicity of a Human Parainfluenza Type 3 (HPIV3) Virus Vaccine in Infants and Children
This study has been completed.
Study NCT01254175   Information provided by National Institute of Allergy and Infectious Diseases (NIAID)

First Received on December 2, 2010.   Last Updated on March 27, 2014   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
More general conditions related to this trial
Interventions listed in this trial
Sponsors listed in this trial